Increased serum IL-19 levels have been observed in various kidney diseases, including in various kidney diseases, including hydronephrosis accompanied by ureteral stones, diabetes, and polycystic kidney disease, as well as in kidney transplant recipients (Table 2). Here, IL19 is linked to ureterolithiasis.